However, many carriers with BMPR2 gene mutations do not develop PAH11, and the mechanisms underlying the roles of the TGF-β/BMP superfamily in the development of PAH have not been fully elucidated. This evidence concerns the gene BMPR2 and pulmonary arterial hypertension.